Close mobile menu×
Close mobile menu

Joseph A. Picoraro, MD

Board Certifications: 
Pediatric Gastroenterology, Pediatrics
Accepting New Patients
Treats Children
Profile Hero

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Credentials & Experience

Board Certifications

  • Pediatric Gastroenterology
  • Pediatrics

Clinical Expertise

  • Eosinophilic Esophagitis
  • Inflammatory Bowel Disease
  • Medical Quality
  • Pediatric Inflammatory Bowel Disease (IBD)

Education & Training

  • MD, University of Pennsylvania School of Medicine
  • Internship: Children's Hospital of Philadelphia
  • Residency: Children's Hospital of Philadelphia
  • Fellowship: Morgan Stanley Children's Hospital of NewYork-Presbyterian

About Joseph Picoraro

Dr. Joseph Picoraro is a pediatric gastroenterologist who strives to provide comprehensive care for each child in the context of his or her family. He specializes in inflammatory bowel disease (IBD), intestinal immunological conditions, eosinophilic esophagitis and congenital diarrhea. He is the Associate Director of the Pediatric IBD Center at Columbia University Irving Medical Center and is the Director of Pediatric GI Inpatient Services at NewYork-Presbyterian Morgan Stanley Children's Hospital. He is an Associate Course Director of the preclinical medical student Foundations in Clinical Medicine – Tutorials course of the Columbia University Vagelos College of Physicians and Surgeons. He serves on the Greater New York Chapter Medical Advisory and Government and Industry Affairs Committees of the Crohn’s and Colitis Foundationand the Clinical Care and Quality Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Dr. Picoraro completed medical school training (MD) at University of Pennsylvania Perelman School of Medicine, internship and residency training in general pediatrics at the Children's Hospital of Philadelphia and pediatric gastroenterology, hepatology and nutrition fellowship training at NewYork-Presbyterian Morgan Stanley Children’s Hospital and Columbia University Irving Medical Center.

Dr. Picoraro is driven to foster a medical system in which children and families are provided targeted treatments while incorporating inclusive decision-making. His research focuses on improving the comprehensive and tailored care of children with gastrointestinal diseases, with a focus on Crohn’s disease and ulcerative colitis.

Academic Titles

  • Assistant Professor of Pediatrics

Committee/Societies/Council Memberships

American Gastroenterological Association

Crohn's and Colitis Foundation

North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

Hospital Affiliations

  • NewYork-Presbyterian Morgan Stanley Children's Hospital
  • NewYork-Presbyterian / Weill Cornell Medical Center

Gender

  • Male

Insurance Accepted

For billing questions, please call (212) 304-7250.

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Research

Pediatric medicine extends the entire lifespan and discovery in children informs our understanding of fundamental mechanisms of human disease. Dr. Picoraro is driven to accelerate clinical innovations, utilizing insights from molecular underpinnings of disease.

Dr. Picoraro’s research focuses on the precision of diagnosis and treatment of children with Crohn’s disease and ulcerative colitis, incorporating systems improvement, care delivery optimization and processes of inclusive decision-making.

Research Interests

  • Clinical decision-making
  • Inflammatory bowel disease (Crohns disease and ulcerative colitis)
  • Medical systems improvement

Clinical Trials

A PHASE 2, RANDOMIZED, DOUBLE-BLIND, DOSE-RANGING STUDY TO DETERMINE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN''S DISEASE

NCT03138655; Project Dates: Jan 11 2018 to Jan 11 2023

A PHASE 2B, EXTENSION STUDY TO DETERMINE THE LONG-TERM SAFETY OF VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN''S DISEASE LONG-TERM SAFETY WITH VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN''S DISEASE

NCT03196427; Project Dates: Jan 11 2018 to Jan 11 2023

Grants

A PHASE 3 RANDOMIZED OPEN LABEL STUDY TO ASSESS THE EFFICACY SAFETY AND PHARMACOKINETICS OF GOLIMUMAB TREATMENT A HUMAN ANTI-TNFA MONOCLONAL ANTIBODY ADMINISTERED SUBCUTANEOUSLY IN PEDIATRIC PARTICPANTS W MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLOTIS. (P&S Industry Clinical Trial)

Apr 18 2019 - Apr 18 2024

APHASE 2B, EXTENSION STUDY TO DETERMINE THE LONG-TERM SAFETY OF VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE LONG-TERM SAFETY WITH VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE (P&S Industry Clinical Trial)

Jan 11 2018 - Jan 11 2023

APHASE 2, RANDOMIZED, DOUBLE-BLIND, DOSE-RANGING STUDY TO DETERMINE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE (P&S Industry Clinical Trial)

Jan 11 2018 - Jan 11 2023

ANOPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE PHARMACOKINETICS OF SINGLE AND MULTIPLE INTRAVENOUS DOSES OF PANTOPRAZOLE IN TWO AGE COHORTS OF HOSPITALIZED PEDIATRIC SUBJECTS 1 TO 16 YEARS OF AGE WHO ARE CANDIDATES FOR ACID SUPPRESSION THERAPY (P&S Industry Clinical Trial)

Nov 16 2017 - Nov 16 2022

AMULTICENTER, PROSPECTIVE, LONGTERM, OBSERVATIONAL REGISTRY OF PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE (Private)

Nov 23 2015 - Nov 22 2020

Selected Publications

Picoraro JA1, Lee D1, Heller CA, Weaver A, Hyams JS, Conklin LS, Otley A, Ziring D, Kugathasan S, Rosh JR, Mulberg A, Denson LA, Kappelman M, Grossman A, Bousvaros A, Park KT. Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD. Inflamm Bowel Dis. 2019 Jan 1;25(1):27-32.

Gluchowski NL, Chitraju C, Picoraro JA, Mejhert N, Pinto S, Xin W, Kamin DS, Winter HS, Chung WK, Walther TC, Farese RV Jr.Identification and Characterization of a Novel DGAT1 Missense Mutation Associated with Congenital Diarrhea. J Lipid Res.2017 Jun;58(6):1230-1237.

Picoraro J, Winberry G, Siegel CA, El-Matary W, Moses J, Grossman A, Park KT. Premedication Use Before Infliximab Administration: A Cross-sectional Analysis. Inflamm Bowel Dis. 2017 Jan;23(1):174-180.

Picoraro JA, Pierog A, Reilly NR, Mencin AA. Gastrojejunal Tube Placement Through an Established Gastrostomy via an Endoscopic Transgastric Approach in a Pediatric Population. Gastrointest Endosc. 2015 Dec;82(6):1025-30.